NLS Pharmaceutics AG (NLSP)
|52 Week Range||0.33-2.83|
|1y Target Est||-|
|DCF Unlevered||NLSP DCF ->|
|DCF Levered||NLSP LDCF ->|
|Debt / Equity||962.84%||Strong Buy|
Upgrades & Downgrades
Latest NLSP news
4 Hot Penny Stocks To Watch This Week
22 August 2022
Penny stocks to add to your watch list this week. The post 4 Hot Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
What Know About Buying Penny Stocks on July 22nd
22 July 2022
Here's what you need to know about buying penny stocks on July 22nd The post What Know About Buying Penny Stocks on July 22nd appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...
NLS Pharma Shares Fall After Mazindol ER Interim Data Shows 39% Improvement On Sleepiness Scale
16 March 2022
NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol ER), in narcolepsy. For excessive daytime sleepiness...
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
7 February 2022
NLS Pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience (Mazindol ER),...
NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with N...
7 February 2022
Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrolling patients Nearly 90% of patients completing the t...
3 Penny Stocks to Watch in the Second Week of January
9 January 2022
Here are three penny stocks to add to your watchlist for next week The post 3 Penny Stocks to Watch in the Second Week of January appeared first on Penny Stocks to Buy, Picks, News and Information | P...
NLS Pharmaceutics Stock (NLSP) Why The Price Surged Today
4 January 2022
The stock price of NLS Pharmaceutics AG (NASDAQ: NLSP) increased by over 80% during intraday trading today. This is why it happened.
NLS Pharmaceutics Announces Preclinical Data Demonstrating the Potential of NLS-4 (Lauflumide) to Tr...
14 October 2021
STANS, SWITZERLAND / ACCESSWIRE / October 14, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and...
NLS Pharmaceutics to Participate in The Micro Cap Rodeo Fall Harvest Conference: Best Ideas from the...
30 September 2021
STANS, SWITZERLAND / ACCESSWIRE / September 30, 2021 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and ...